GIQuant®
MotilentProduct specifications |
Information source:
Vendor
Last updated: Nov. 24, 2021 |
General | |
---|---|
Product name | GIQuant® |
Company | Motilent |
Subspeciality | Abdomen |
Modality | MR |
Disease targeted | Crohn’s Disease, Irritable Bowel Syndrome (IBS) and Gastroparesis |
Key-features | Intestinal motility scoring, motility visualization |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps) |
Data characteristics | |
Population | Adults and children suffering with, or with the suspicion of, diseases or conditions affecting the small bowel (e.g. Crohn’s Disease). |
Input | Cine MRI, Magnetic Resonance Enterography, Abdominal, Steady-state free-precession, SSFP |
Input format | DICOM |
Output | Parametric Map, Anatomical Reference Image, Structured Report |
Output format | DICOM |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform |
Deployment | Locally virtualized (virtual machine, docker) |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | > 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 06-2019 |
Distribution channels | Nuance AI marketplace |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Subscription |
Based on | |
Evidence | |
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |